BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 21954478)

  • 21. A detailed safety assessment of a saw palmetto extract.
    Avins AL; Bent S; Staccone S; Badua E; Padula A; Goldberg H; Neuhaus J; Hudes E; Shinohara K; Kane C
    Complement Ther Med; 2008 Jun; 16(3):147-54. PubMed ID: 18534327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial.
    Lopatkin N; Sivkov A; Walther C; Schläfke S; Medvedev A; Avdeichuk J; Golubev G; Melnik K; Elenberger N; Engelmann U
    World J Urol; 2005 Jun; 23(2):139-46. PubMed ID: 15928959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gerber GS; Fitzpatrick JM
    BJU Int; 2004 Aug; 94(3):338-44. PubMed ID: 15291864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China. R. Shi, Q. Xie, X. Gang, J. Lun, L. Cheng, A. Pantuck and J. Rao. J Urol 2008; 179: 610-615.
    Ozdemir AT; Serefoglu EC; Balbay MD
    J Urol; 2008 Sep; 180(3):1188; author reply 1188. PubMed ID: 18639898
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
    Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
    BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saw palmetto and lower urinary tract symptoms: what is the latest evidence?
    Avins AL; Bent S
    Curr Urol Rep; 2006 Jul; 7(4):260-5. PubMed ID: 16930496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
    Kaplan SA; Volpe MA; Te AE
    J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Lowe F; Roehrborn C
    BJU Int; 2004 Apr; 93(6):751-6. PubMed ID: 15049985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pygeum africanum for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
    Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign prostatic hyperplasia treated with saw palmetto: a literature search and an experimental case study.
    McPartland JM; Pruitt PL
    J Am Osteopath Assoc; 2000 Feb; 100(2):89-96. PubMed ID: 10732392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms--long-term follow-up of a placebo-controlled, double-blind, multicenter trial.
    Lopatkin N; Sivkov A; Schläfke S; Funk P; Medvedev A; Engelmann U
    Int Urol Nephrol; 2007; 39(4):1137-46. PubMed ID: 18038253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms.
    Barry MJ; Cantor A; Roehrborn CG;
    J Urol; 2013 Mar; 189(3):987-92. PubMed ID: 23017510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
    Lee J; Andriole G; Avins A; Crawford ED; Foster H; Kaplan S; Kreder K; Kusek J; McCullough A; McVary K; Meleth S; Naslund M; Nickel JC; Nyberg L; Roehrborn C; Dale Williams O; Barry M
    Clin Trials; 2009 Dec; 6(6):628-36. PubMed ID: 20007408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.
    Willetts KE; Clements MS; Champion S; Ehsman S; Eden JA
    BJU Int; 2003 Aug; 92(3):267-70. PubMed ID: 12887481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial Effects of Saw Palmetto Fruit Extract on Urinary Symptoms in Japanese Female Subjects by a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
    Yamada S; Shirai M; Ono K; Kageyama S
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
    Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
    Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.
    Sökeland J
    BJU Int; 2000 Sep; 86(4):439-42. PubMed ID: 10971268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of HT080 for lower urinary tract symptoms associated with benign prostatic hyperplasia: A study protocol for a randomized, double-blind, placebo-controlled trial.
    Song J; Lee SH; Kim H
    Medicine (Baltimore); 2019 Nov; 98(45):e17848. PubMed ID: 31702643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saw palmetto and benign prostatic hyperplasia.
    Gong EM; Gerber GS
    Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.